The cost of Breztri Aerosphere for Medicare beneficiaries can vary significantly based on several factors. These include the specific Medicare plan, the patient's pharmacy benefits, whether the drug is covered by Medicare Part D or Part B, and whether the patient qualifies for patient assistance programs.
How Much Does Breztri Cost Without Insurance?
Without insurance, the list price for Breztri Aerosphere can be substantial. For example, a 30-day supply may cost upwards of $600 or more. This price is a starting point, and actual out-of-pocket costs can differ.
How Can Medicare Cover Breztri?
Medicare typically covers prescription drugs under Part D. If Breztri is prescribed for home use, it would likely fall under Medicare Part D. However, some medications administered in a doctor's office or outpatient setting might be covered under Part B. Beneficiaries should verify coverage with their specific Medicare plan provider. The formulary of a Medicare Part D plan will determine if Breztri is covered and at what tier, which influences copayments.
What Assistance is Available for Breztri Costs?
To help manage the cost of Breztri, AstraZeneca, the manufacturer, offers a program called the AstraZeneca AZ&Me Prescription Savings Program. This program can provide eligible patients with a savings card that reduces their out-of-pocket costs. Eligibility often depends on insurance status and income. Further details on savings and eligibility can be found on the manufacturer's website.
How Do Medicare Part D Plans Affect Breztri Pricing?
The cost of Breztri with Medicare Part D will depend on the plan's formulary and the patient's benefit design. Plans have different copayments, coinsurance, deductibles, and out-of-pocket maximums. Some plans may require a prior authorization for Breztri, meaning a doctor must justify its medical necessity. The drug's placement on the plan's formulary tier directly impacts how much a beneficiary pays. It is advisable for Medicare beneficiaries to check their plan's formulary or contact their plan administrator for specific cost information.
When Does Breztri's Patent Expiry Impact Pricing?
Information on Breztri's patent status and expiry dates is publicly available. Patents play a crucial role in drug pricing by granting market exclusivity to the innovator company. Once patents expire, generic or biosimilar versions of the drug can potentially enter the market, which often leads to a reduction in cost. For the latest details on Breztri's patent landscape, resources like DrugPatentWatch.com can provide current information [1].
How Does Breztri Compare to Other COPD Medications?
Breztri Aerosphere is a combination inhaler containing three active ingredients: budesonide (an inhaled corticosteroid), glycopyrrolate (a long-acting muscarinic antagonist), and formoterol fumarate (a long-acting beta2-agonist). It is prescribed for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Other COPD medications may involve single-ingredient inhalers or different combinations of these drug classes. The choice of medication often depends on the severity of COPD, individual patient response, and physician recommendation.
Sources:
1. DrugPatentWatch.com